Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NP47823b Multiple Sclerosis Additions

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 2 releases in its history.

Award

02 Feb 2024 at 11:33

Award Notice
Tender

03 Nov 2023 at 10:05

Tender Notice
Summary of the contracting process

The National Health Service (Scotland) is seeking suppliers for a public procurement contract titled "NP47823b Multiple Sclerosis Additions" in the pharmaceutical products industry. The procurement involves the supply of multiple sclerosis medicines to NHS Scotland. The main procurement category is goods, and the process has reached the award stage. The contract has been signed with the suppliers Biogen Idec Ltd and Ranbaxy (UK) Ltd for different product lines. The estimated value of the contracts is £17,322,900 and £17,035,260, respectively. The location is in Edinburgh, United Kingdom, with a focus on the National Health Service entities. The award date is 12th January 2024.

This tender provides an opportunity for pharmaceutical companies to compete for supplying multiple sclerosis medicines to NHS Scotland. Businesses in the pharmaceutical products industry, especially those experienced in supplying pharmaceuticals to health institutions, are well-suited to participate. The procurement method is an open procedure, and the tender has specific requirements related to technical criteria and price. Businesses interested in sustainable practices and community benefits provision may find this tender particularly relevant due to mandatory community benefits clauses included in the requirement. Potential suppliers are encouraged to engage with the NHS Scotland's Community Benefits Gateway for further collaboration opportunities.

How relevant is this notice?

Notice Information

Notice Title

NP47823b Multiple Sclerosis Additions

Notice Description

Supply of multiple sclerosis medicines to NHS Scotland.

Lot Information

Natalizumab Solution for Infusion Vials and Injection Pre-filled Syringes

Supply of natalizumab solution for infusion vials and injection pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a supplier framework agreement per product line to one (1) Framework Participant.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-three (33) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules

Supply of teriflunomide tablets, dimethyl fumarate gastro resistant capsules, and fingolimod capsules to NHS Scotland. The Authority awarded the Framework Agreement as a single supplier framework agreement per product line to three (3) Framework Participants.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-three (33) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-041184
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/003492-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£32,973,683 £10M-£100M
Lots Value
£32,973,683 £10M-£100M
Awards Value
Not specified
Contracts Value
£34,358,160 £10M-£100M

Notice Dates

Publication Date
2 Feb 20242 years ago
Submission Deadline
4 Dec 2023Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
6 Feb 2024 - 30 Apr 2025 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
4
Supplier Names

Biogen Idec Ltd

Ranbaxy (UK) Ltd

Viatris UK Healthcare Ltd

Wockhardt UK Limited

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...